114 related articles for article (PubMed ID: 3778569)
1. [Plasma concentrations of fosfestrol as well as diethylstilbestrol on their conjugates following intravenous administration on prostatic carcinoma patients].
Oelschläger H; Rothley D; Dunzendorfer U
Arzneimittelforschung; 1986 Aug; 36(8):1284-9. PubMed ID: 3778569
[TBL] [Abstract][Full Text] [Related]
2. [Drug therapy of metastasizing prostate carcinoma with special reference to the bioavailability of fosfestrol after oral administration].
Oelschläger H; Rothley D; Dunzendorfer U
Arzneimittelforschung; 1988 Oct; 38(10):1502-12. PubMed ID: 3058134
[TBL] [Abstract][Full Text] [Related]
3. [Plasma levels of fosfestrol and its monophosphate, of diethylstilbestrol and its monoglucuronide following intravenous administration in patients with metastatic prostatic carcinoma].
Oelschläger H; Rothley D; Dunzendorfer U
Arzneimittelforschung; 1984; 34(10):1333-6. PubMed ID: 6542793
[TBL] [Abstract][Full Text] [Related]
4. [Direct determination of diethylstilbestrol and its monoconjugates in plasma].
Oelschläger H; Rothley D; Dunzendorfer U
Arzneimittelforschung; 1986 Apr; 36(4):759-63. PubMed ID: 3718601
[TBL] [Abstract][Full Text] [Related]
5. [Direct approximation of plasma concentration time curves of 3-diethylstilbestrol monoglucuronide following oral and intravenous administration of fosfestrol].
Rothley D; Oelschläger H
Pharmazie; 1986 Dec; 41(12):862-4. PubMed ID: 3575391
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
[TBL] [Abstract][Full Text] [Related]
7. Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate.
Kemp HA; Read GF; Riad-Fahmy D; Pike AW; Gaskell SJ; Queen K; Harper ME; Griffiths K
Cancer Res; 1981 Nov; 41(11 Pt 1):4693-7. PubMed ID: 7306985
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability, distribution and pharmacokinetics of diethylstilbestrol converted from diethylstilbestrol diphosphate in patients with prostatic cancer.
Nakamura K
Hiroshima J Med Sci; 1986 Dec; 35(4):325-38. PubMed ID: 3570844
[No Abstract] [Full Text] [Related]
9. The pharmacokinetics of fosfestrol and diethylstilbestrol in chronic hemodialysis patients with prostate cancer.
Hatori M; Totuka Y; Yamanaka H
Int J Urol; 2001 Dec; 8(12):681-5. PubMed ID: 11851768
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and metabolism of E-DES-diphosphate.
Oelschläger H; Rothley D; Dunzendorfer U
Prog Clin Biol Res; 1989; 303():187-95. PubMed ID: 2780647
[No Abstract] [Full Text] [Related]
11. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
Ohuchi H; Noguchi K; Kinoshita Y; Hosaka M; Kawasaki C; Miura T; Kondo I; Harada M
Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371
[TBL] [Abstract][Full Text] [Related]
12. [Honvan-high-dose therapy of prostatic carcinoma with metastases: early complications and value of prophylaxis against thrombosis].
Heinz A; Meyer WW; Hallwachs O
Urologe A; 1982 Jul; 21(4):232-4. PubMed ID: 6890263
[TBL] [Abstract][Full Text] [Related]
13. Role of the mitochondrial bc1-complex in the cytotoxic action of diethylstilbestrol-diphosphate toward prostatic carcinoma cells.
Schulz P; Link TA; Chaudhuri L; Fittler F
Cancer Res; 1990 Aug; 50(16):5008-12. PubMed ID: 2165852
[TBL] [Abstract][Full Text] [Related]
14. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
15. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
[TBL] [Abstract][Full Text] [Related]
16. [High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma].
Kattan J; Droz JP; Culine S
Bull Cancer; 1993 Mar; 80(3):248-54. PubMed ID: 8173177
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with Honvan therapy in carcinoma of the prostate].
Joó GD
Med Welt; 1966 Jan; 1():61-4. PubMed ID: 5942368
[No Abstract] [Full Text] [Related]
18. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
Noland JL; Amin M
Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability, distribution and pharmacokinetics of diethystilbestrol produced from stilphostrol.
Abramson FP; Miller HC
J Urol; 1982 Dec; 128(6):1336-9. PubMed ID: 7154205
[TBL] [Abstract][Full Text] [Related]
20. [Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
Carstensen HE; Olsen CE; Sele V; Brorson I; Jensen E; Nissen NI; Fabricius J
Nord Med; 1969 Jan; 81(4):111-4. PubMed ID: 4888811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
